Advertisement

Control of extended-spectrum β-lactamase–producing Enterobacteriaceae nosocomial acquisition in an intensive care unit: A time series regression analysis

Published:September 10, 2015DOI:https://doi.org/10.1016/j.ajic.2015.07.026

      Background

      This study was undertaken to determine the temporal relationship between implementation of different interventions in an intensive care unit (ICU) and control of endemic nosocomial acquisition of extended-spectrum β-lactamase Enterobacteriaceae (ESBLE).

      Methods

      This was a prospective observational study with time-series analysis of the monthly incidence of ESBLE and its predictors. In November 2007, after a 14-month baseline period, an intervention consisting of restriction of third-generation cephalosporins (3 GC) and increased use of alcohol-based hand rubs was implemented. In January 2008, an increased health care worker (HCW):patient ratio was also implemented. In March 2010, the ICU was closed, and patients were moved to a clean ICU.

      Results

      The first intervention resulted in global reduction in 3 GC and increased use of alcohol-based hand rub. A significant change in ESBLE incidence was observed in a full segmented univariate regression analysis (mean change in level, −0.91 ± 0.19; P < .0001). After ICU closure, there was a dramatic reduction in ESBLE acquisition. According to the multivariate model, the ICU closure was the main protective factor. Before ICU closure, an increase in the HCW:patient ratio of 0.1 point tended to be associated with a decreased risk of ESBLE acquisition (relative risk, 0.28; 95% confidence interval, 0.06-1.25; P = .09).

      Conclusions

      This study shows that ICU closure was associated with, but not necessarily the reason for, control of ESBLE cross-transmission in a nonoutbreak setting. Environmental ESBE sources may play a role in cross-transmission.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lin M.F.
        • Huang M.L.
        • Lai S.H.
        Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan.
        J Hosp Infect. 2003; 53: 39-45
        • Cordery R.J.
        • Roberts C.H.
        • Cooper S.J.
        • Bellinghan G.
        • Shetty N.
        Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase–producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
        J Hosp Infect. 2008; 68: 108-115
        • Boucher H.W.
        • Talbot G.H.
        • Bradley J.S.
        • Edwards J.E.
        • Gilbert D.
        • Rice L.B.
        • et al.
        Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.
        Clin Infect Dis. 2009; 48: 1-12
        • Razazi K.
        • Derde L.P.
        • Verachten M.
        • Legrand P.
        • Lesprit P.
        • Brun-Buisson C.
        Clinical impact and risk factors for colonization with extended-spectrum ß-lactamase–producing bacteria in the intensive care unit.
        Intensive Care Med. 2012; 38: 1769-1778
        • Harris A.D.
        • Perencevich E.N.
        • Johnson J.K.
        • Paterson D.L.
        • Morris J.G.
        • Strauss S.M.
        • et al.
        Patient-to-patient transmission is important in extended-spectrum ß-lactamase–producing Klebsiella pneumoniae acquisition.
        Clin Infect Dis. 2007; 45: 1347-1350
        • Tschudin-Sutter S.
        • Frei R.
        • Dangel M.
        • Stranden A.
        • Widmer A.F.
        Rate of transmission of extended-spectrum beta-lactamase–producing Enterobacteriaceae without contact isolation.
        Clin Infect Dis. 2012; 55: 1505-1511
        • Lautenbach E.
        • Patel J.B.
        • Bilker W.B.
        • Edelstein P.H.
        • Fishman N.O.
        Extended-spectrum beta-lactamase–producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
        Clin Infect Dis. 2001; 32: 1162-1171
        • Goddard S.
        • Muller M.P.
        The efficacy of infection control interventions in reducing the incidence of extended-spectrum ß-lactamase–producing Enterobacteriaceae in the nonoutbreak setting: a systematic review.
        Am J Infect Control. 2011; 39: 599-601
        • Meyer E.
        • Lapatschek M.
        • Bechtold A.
        • Schwarzkopf G.
        • Gastmeier P.
        • Schwab F.
        Impact of restriction of third-generation cephalosporins on the burden of third-generation cephalosporin-resistant K. pneumoniae and E. coli in an ICU.
        Intensive Care Med. 2009; 35: 862-870
        • Kaier K.
        • Frank U.
        • Hagist C.
        • Conrad A.
        • Meyer E.
        The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase–producing strains: a time-series analysis.
        J Antimicrob Chemother. 2009; 63: 609-614
        • Jarlier V.
        • Nicolas M.H.
        • Fournier G.
        • Philippon A.
        Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
        Rev Infect Dis. 1988; 10: 867-878
        • Mahamat A.
        • MacKenzie F.M.
        • Brooker K.
        • Monnet D.L.
        • Daures J.P.
        • Gould I.M.
        Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis.
        Int J Antimicrob Agents. 2007; 30: 169-176
        • Wagner A.K.
        • Soumerai S.B.
        • Zhang F.
        • Ross-Degnan D.
        Segmented regression analysis of interrupted time series studies in medication use research.
        J Clin Pharm Ther. 2002; 27: 299-309
        • Nijssen S.
        • Fluit A.
        • van de Vijver D.
        • Top J.
        • Willems R.
        • Bonten M.J.
        Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria.
        Intensive Care Med. 2010; 36: 512-519
        • Thiebaut A.C.
        • Arlet G.
        • Andremont A.
        • Papy E.
        • Sollet J.P.
        • Bernède-Bauduin C.
        • et al.
        Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
        J Antimicrob Chemother. 2012; 67: 1525-1536
        • Eisen D.
        • Russell E.G.
        • Tymms M.
        • Roper E.J.
        • Grayson M.L.
        • Turnidge J.
        Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae.
        J Clin Microbiol. 1995; 33: 713-717
        • Roux D.
        • Aubier B.
        • Cochard H.
        • Quentin R.
        • van der Mee-Marquet N.
        Contaminated sinks in intensive care units: an underestimated source of extended-spectrum beta-lactamase–producing Enterobacteriaceae in the patient environment.
        J Hosp Infect. 2013; 85: 106-111
        • Guet-Revillet H.
        • Le Monnier A.
        • Breton N.
        • Descamps P.
        • Lecuyer H.
        • Alaabouche I.
        • et al.
        Environmental contamination with extended-spectrum beta-lactamases: is there any difference between Escherichia coli and Klebsiella spp?.
        Am J Infect Control. 2012; 40: 845-848
        • Gbaguidi-Haore H.
        • Talon D.
        • Hocquet D.
        • Bertrand X.
        Hospital environmental contamination with Enterobacteriaceae producing extended-spectrum beta-lactamase.
        Am J Infect Control. 2013; 41: 664-665
        • Harbarth S.
        • Sudre P.
        • Dharan S.
        • Cadenas M.
        • Pittet D.
        Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices.
        Infect Control Hosp Epidemiol. 1999; 20: 598-603
        • Kaier K.
        • Meyer E.
        • Dettenkofer M.
        • Frank U.
        Epidemiology meets econometrics: using time-series analysis to observe the impact of bed occupancy rates on the spread of multidrug-resistant bacteria.
        J Hosp Infect. 2010; 76: 108-113
        • Schwab F.
        • Meyer E.
        • Geffers C.
        • Gastmeier P.
        Understaffing, overcrowding, inappropriate nurse:ventilated patient ratio, and nosocomial infections: which parameter is the best reflection of deficits?.
        J Hosp Infect. 2012; 80: 133-139
        • Zahar J.R.
        • Masse V.
        • Watier L.
        • Lanternier F.
        • Degand N.
        • Postaire M.
        • et al.
        Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase–producing Enterobacteriaceae (ESBL-PE)-acquired infections?.
        J Hosp Infect. 2012; 80: 348-350
        • Garcia San Miguel L.
        • Cobo J.
        • Valverde A.
        • Coque T.M.
        • Diz S.
        • Grill F.
        • et al.
        Clinical variables associated with the isolation of Klebsiella pneumoniae expressing different extended-spectrum beta-lactamases.
        Clin Microbiol Infect. 2007; 13: 532-538
        • Shardell M.
        • Harris A.D.
        • El-Kamary S.S.
        • Furuno J.P.
        • Miller R.R.
        • Perencevich E.N.
        Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies.
        Clin Infect Dis. 2007; 45: 901-907